100 related articles for article (PubMed ID: 11280214)
61. Successful treatment of hepatitis B virus (HBV)-associated membranoproliferative glomerulonephritis (MPGN) with alpha interferon.
Abbas NA; Pitt MA; Green AT; Solomon LR
Nephrol Dial Transplant; 1999 May; 14(5):1272-5. PubMed ID: 10344378
[No Abstract] [Full Text] [Related]
62. Paraneoplastic immunoglobulin A nephropathy and associated focal segmental glomerulosclerosis in asymptomatic low volume B-cell lymphoma - a case report.
Ng MSY; Francis L; Pillai E; Mallett AJ
BMC Nephrol; 2018 Sep; 19(1):224. PubMed ID: 30200898
[TBL] [Abstract][Full Text] [Related]
63. Characterization of proteinuria in asymptomatic family members and household contacts of children with hepatitis B virus-associated membranous nephropathy.
Bhimma R; Coovadia HM; Ramjee G; Kramvis A; Adhikari M; Kew MC; Connolly CA
Am J Kidney Dis; 2001 Jan; 37(1):125-133. PubMed ID: 11136177
[TBL] [Abstract][Full Text] [Related]
64. Treatment of nephrotic syndrome with cyclosporin A. What remains in 1994?
Meyrier A
Nephrol Dial Transplant; 1994; 9(6):596-8. PubMed ID: 7970083
[No Abstract] [Full Text] [Related]
65. Treatment of glomerular diseases: pioneering clinical trials.
Radhakrishnan J
Kidney Int; 2020 Mar; 97(3):433-436. PubMed ID: 32087882
[No Abstract] [Full Text] [Related]
66. Interferon treatment of hepatitis B-associated membranous glomerulonephritis and nephrotic syndrome.
Giboa N; Neigut D
Pediatr Nephrol; 1993 Jun; 7(3):328-9. PubMed ID: 8518110
[No Abstract] [Full Text] [Related]
67. Deep learning-based framework for the distinction of membranous nephropathy: a new approach through hyperspectral imagery.
Tu T; Wei X; Yang Y; Zhang N; Li W; Tu X; Li W
BMC Nephrol; 2021 Jun; 22(1):231. PubMed ID: 34147076
[TBL] [Abstract][Full Text] [Related]
68. Effects of melanocortin 1 receptor agonists in experimental nephropathies.
Lindskog Jonsson A; Granqvist A; Elvin J; Johansson ME; Haraldsson B; Nyström J
PLoS One; 2014; 9(1):e87816. PubMed ID: 24498203
[TBL] [Abstract][Full Text] [Related]
69. Role of interferon-alpha in the treatment of primary glomerulonephritis.
Al-Wakeel J; Mitwalli A; Tarif N; Al-Mohaya S; Malik G; Khalil M
Am J Kidney Dis; 1999 Jun; 33(6):1142-6. PubMed ID: 10352204
[TBL] [Abstract][Full Text] [Related]
70. Authors' Reply: "On the Importance of Considering Glycosylation when Evaluating Biologic Therapies".
Angeletti A; Ravani P; Bruschi M; Ghiggeri GM
J Am Soc Nephrol; 2022 Aug; 33(8):1626. PubMed ID: 35840170
[No Abstract] [Full Text] [Related]
71. Collapsing focal segmental glomerulosclerosis with recovery of renal function: an uncommon complication of interferon therapy for hepatitis C.
Stein DF; Ahmed A; Sunkhara V; Khalbuss W
Dig Dis Sci; 2001 Mar; 46(3):530-5. PubMed ID: 11318527
[No Abstract] [Full Text] [Related]
72. Interferon treatment in hepatitis B virus-associated membranous glomerulopathy.
Kavukçu S; Başdemir G; Eroğlu Y; Türkmen M; Eser F; Büyükgebiz B
Pediatr Nephrol; 1995 Aug; 9(4):539-40. PubMed ID: 7577424
[No Abstract] [Full Text] [Related]
73. Incidences of membranous nephropathy versus focal segmental glomerulosclerosis: increase in the former or decline in the latter?
Haas M
Clin Kidney J; 2013 Aug; 6(4):365-7. PubMed ID: 27293561
[No Abstract] [Full Text] [Related]
74. Another case of focal segmental glomerulosclerosis in an acutely uraemic patient following interferon therapy.
Dressler D; Wright JR; Houghton JB; Kalra PA
Nephrol Dial Transplant; 1999 Aug; 14(8):2049-50. PubMed ID: 10462305
[No Abstract] [Full Text] [Related]
75. Segmental NELL-1 Membranous Nephropathy Complicating Tiopronin Therapy.
Santoriello D; Ramaswamy R; Kudose S; Markowitz GS
Kidney Int Rep; 2023 Aug; 8(8):1683-1686. PubMed ID: 37547528
[No Abstract] [Full Text] [Related]
76. [Effect of interferon therapy on hepatitis B virus related membranous nephropathy associated with focal segmental glomerulosclerosis].
Iwata Y; Wada T; Yoshimoto K; Sakai N; Shimizu M; Furuichi K; Hisada Y; Kobayashi K; Yokoyama H
Nihon Jinzo Gakkai Shi; 2001; 43(2):76-81. PubMed ID: 11280214
[TBL] [Abstract][Full Text] [Related]
77. [Treatment of hepatitis B virus-associated membranous glomerulonephritis with interferon alfa in a 7 year old boy].
Steiss JO; Piske-Keyser K; Gröne HJ; Gortner L
Klin Padiatr; 2000; 212(5):283-6. PubMed ID: 11048290
[TBL] [Abstract][Full Text] [Related]
78. Hepatitis C--associated glomerular disease in liver transplant recipients.
Davis CL; Gretch DR; Perkins JD; Harris AW; Wener MH; Alpers CE; Lesniewski R; Lee W; dela Rosa C; Johnson RJ
Liver Transpl Surg; 1995 May; 1(3):166-75. PubMed ID: 9346560
[TBL] [Abstract][Full Text] [Related]
79. Hepatitis B virus-related polyarteritis nodosa and membranous nephropathy.
Mouthon L; Deblois P; Sauvaget F; Meyrier A; Callard P; Guillevin L
Am J Nephrol; 1995; 15(3):266-9. PubMed ID: 7618654
[TBL] [Abstract][Full Text] [Related]
80. Hepatitis B virus associated focal and segmental glomerular sclerosis: report of two cases and review of literature.
Khaira A; Upadhyay BK; Sharma A; Das P; Mahajan S; Makhariya G; Dinda AK; Agarwal SK; Tiwari SC
Clin Exp Nephrol; 2009 Aug; 13(4):373-377. PubMed ID: 19169768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
